To evaluate the use of preserved scleral graft with amniotic membrane transplantation (AMT) for the surgical repair of scleromalacia.
A prospective study of eight eyes (eight patients) was performed. We grafted glycerin-preserved sclera onto the areas of scleral thinning with impending perforation and then covered them with an amniotic membrane with a thick basement membrane instead of a conjunctival flap.
All patients experienced loss of ocular pain and inflammation, rapid reepithelialization of the ocular surface, and marked improvement in visual acuity. All of the scleral grafts remained intact, and no recurrence of scleromalacia was observed.
Preserved scleral graft with AMT was simple, fast, and effective. It was particularly advantageous when large scleral defects or conjunctival scarring was present. With these therapeutic results, preserved scleral graft with AMT qualifies as a new treatment alternative for scleromalacia.
From the Department of Ophthalmology, Chung-Ang University Hospital, Seoul, Korea.Proprietary interest category: None.
Submitted July 29, 2002.
Revision received February 25, 2003.
Accepted March 4, 2003.
Supported by a grant from Good Health Project (01-PJ1-PG4–01PT02–0002), Ministry of Health and Welfare, Korea.
Address correspondence and reprint requests to J.C. Kim, M.D., Department of Ophthalmology, Chung-Ang University Hospital, Hangang-Ro 3ka 65-207, Yongsan-ku, 140-757 Seoul, Korea. E-mail: firstname.lastname@example.org